RTI Surgical expects 2018 revenues to land at $280M+ — 5 insights

Biologics

RTI Surgical laid out its 2018 guidance and long-term financial goals.

Here are five insights:

 

1. RTI Surgical expects full-year 2018 revenues to hit between $280 million and $290 million.

 

2. The company anticipates full-year 2018 EBITDA to fall between $32 million and $38 million.

 

3. The company expects its acquisition of Zyga Technology, announced Jan. 4, will lead to revenue growth.

 

4. Within the next five years, RTI Surgical plans to boost revenue to more than $500 million.

 

5. Additionally, the company hopes to double its EBITDA margin to more than 20 percent in the next five years.

 

 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers